• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Biotech

    Parabilis Medicines Secures $305M Funding For FOG-001 Trials

    BUSINESSWIRE

    Parabilis Medicines Showcases Positive Early Data

    BUSINESSWIRE

    Parabilis Medicines Secures FDA Fast Track for FOG-001

    BUSINESSWIRE

    Parabilis Shows Helicon Peptide Data at AACR-NCI-EORTC 2025

    BUSINESSWIRE

    Parabilis Presents Helicon Peptide Data at AACR-NCI-EORTC

    BUSINESSWIRE

    Parabilis Shows First-Ever Drugging of Cancer Driver FOG-001

    BUSINESSWIRE

    Parabilis To Present Ph1/2 FOG-001 Study On ?-Catenin Inhibitor

    BUSINESSWIRE

    Fog clears to reveal Parabilis, a rebranded cancer biotech

    FIERCE PHARMA

    FogPharma, ARTBIO Partner to Develop Helicon-Enabled ARTs (HEARTs)

    BUSINESSWIRE

    FogPharma Announces First Patient Dosed in Phase 1/2 Clinical Trial of FOG-001

    BUSINESSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.